Biocure Technology Inc. (BICTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -217.12 Thousand | -818.37 Thousand | -856.55 Thousand | -1.02 Million | -2.06 Million | -2.58 Million |
| Net Income | -1.49 Million | -403.4 Thousand | -1.46 Million | -2.31 Million | -3.65 Million | -6.58 Million |
| Depreciation & Amortization | - | - | -60.77 Thousand | -43.09 Thousand | -34.55 Thousand | 51.88 Thousand |
| Deferred income taxes | - | - | -1.11 Million | -127.3 Thousand | -1.54 Million | 97.74 Thousand |
| Stock-based compensation | - | - | 1.16 Million | 109.25 Thousand | 1.57 Million | 3.24 Million |
| Change in working capital | 253.34 Thousand | 501.44 Thousand | 196.79 Thousand | 1.41 Million | 301.06 Thousand | 575.01 Thousand |
| Other non-cash items | 7687.00 | -916.41 Thousand | 424.64 Thousand | -70.62 Thousand | 1.28 Million | 28.08 Thousand |
| Investing Cash Flow | 43.3 Thousand | 74.79 Thousand | 21.51 Thousand | 71.81 Thousand | 546.46 Thousand | -972.95 Thousand |
| Investments in PPE | - | - | -3936.00 | -2245.68 | -809.42 Thousand | -938.8 Thousand |
| Acquisitions | - | - | - | - | 1.35 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 45 Thousand | 74.79 Thousand | 25.45 Thousand | 74.05 Thousand | 0.41 | -34.15 Thousand |
| Financing Cash Flow | 140.38 Thousand | 630.93 Thousand | 924.04 Thousand | 890.07 Thousand | 1.49 Million | 2.6 Million |
| Debt repayment | -47 Thousand | - | -102.02 Thousand | -126.01 Thousand | -1.49 Million | -784.3 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 781.63 Thousand | 773.45 Thousand | 1.75 Million | - |
| Other Financing Activities | 187.38 Thousand | 630.93 Thousand | 244.43 Thousand | 242.64 Thousand | 1.22 Million | 2.6 Million |
| Accounts receivables | 15.42 Thousand | -8400.19 | -4504.84 | 15.97 Thousand | -44.64 Thousand | 7739.00 |
| Accounts payables | - | 334.05 Thousand | 238.27 Thousand | 1.4 Million | 337.12 Thousand | - |
| Inventory | - | - | 41.00 | 5726.84 | 5845.38 | 10.65 Thousand |
| Other working capital | 237.92 Thousand | 175.79 Thousand | -37.02 Thousand | -12.31 Thousand | 2739.53 | 564.36 Thousand |
| Cash at beginning of period | 37.67 Thousand | 157.48 Thousand | 46.67 Thousand | 132.43 Thousand | 108.61 Thousand | 1.08 Million |
| Cash at end of period | 4235.00 | 37.67 Thousand | 159.09 Thousand | 46.67 Thousand | 132.43 Thousand | 108.61 Thousand |
| Capital Expenditure | - | - | -3936.00 | -2245.68 | -809.42 Thousand | -938.8 Thousand |
| Effect of forex changes on cash | - | 1.02 | 30.99 Thousand | -1009.00 | 64.53 Thousand | -16.83 Thousand |
| Net cash flow / Change in cash | -33.43 Thousand | -119.8 Thousand | 112.41 Thousand | -85.76 Thousand | 23.82 Thousand | -974.73 Thousand |
| Free Cash Flow | -217.12 Thousand | -818.37 Thousand | -860.49 Thousand | -1.03 Million | -2.87 Million | -3.52 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.66 Thousand | -17.53 Thousand | -1.49 Million | -2.99 Million | -83.29 Thousand | 2.02 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 31.52 Thousand | 15.68 Thousand | 253.34 Thousand | 94.67 Thousand | 13.96 Thousand | 59.82 Thousand |
| Other non-cash items | -1868.57 | 3489.47 | 7687.00 | 2.93 Million | 63.86 Thousand | -2.09 Million |
| Investing Cash Flow | - | - | 43.3 Thousand | 364.62 | 161.79 | 14.43 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 45 Thousand | 364.62 | 161.79 | 14.43 Thousand |
| Financing Cash Flow | - | - | 140.38 Thousand | -36.03 Thousand | 711.20 | -7211.96 |
| Debt repayment | - | - | -47 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 187.38 Thousand | -655.64 | 711.20 | -7211.96 |
| Accounts receivables | 3476.09 | -2160.71 | 15.42 Thousand | -2284.25 | 1106.51 | 15.41 Thousand |
| Accounts payables | - | - | - | - | - | 45.52 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 28.04 Thousand | 17.84 Thousand | - | 96.95 Thousand | 12.85 Thousand | -1111.00 |
| Cash at beginning of period | 2605.85 | 3195.31 | 37.67 Thousand | 4019.11 | 8791.02 | 7981.82 |
| Cash at end of period | 21.18 Thousand | 2605.85 | 4235.00 | 3195.31 | 4019.11 | 8791.02 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 0.05 | -173.66 | -6.00 |
| Net cash flow / Change in cash | 18.57 Thousand | -589.46 | -33.43 Thousand | -823.80 | -4771.92 | 809.20 |
| Free Cash Flow | 18.45 Thousand | -520.43 | -217.12 Thousand | 35.16 Thousand | -5471.25 | -6826.41 |
1910
XAARF
VTEPF
2881
688277
TBLMF